Gene · 5150
Papers669
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 669
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Both Conserved Aromatic Nature and Critical RNA Motif of Residue 67 in the ToBRFV Movement Protein May Be Essential for Evading Tm-22-Mediated Resistance. | Mol Plant Pathol | 2026 | 42438102 | PubTator, text mining | PubMed |
| Heterocyclic Scaffolds as Therapeutic Agents in Multiple Sclerosis: Mechanisms and SAR Study. | Cent Nerv Syst Agents Med Chem | 2026 | 42393898 | PubTator, text mining | PubMed |
| Tomato Brown Rugose Fruit Virus Evades Tm-22-Mediated Resistance by Avoiding the Induction of Tm-22 Self-Association. | Mol Plant Pathol | 2026 | 41852156 | PubTator, text mining | PubMed |
| Biological implications and therapeutic potential of phosphodiesterase inhibitors: A review. | Medicine (Baltimore) | 2026 | 41790675 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomic Profile Associated with Sub-Subtype A6 and CRF63-02A6 HIV-1 Strain Infection. | Viruses | 2026 | 41754547 | PubTator, text mining | PubMed |
| Family-Wide Dysregulation of Phosphodiesterases Alters cAMP/cGMP Microdomains in Thoracic Aortic Aneurysm. | J Cardiovasc Dev Dis | 2026 | 41590850 | PubTator, text mining | PubMed |
| Integrative multi-omics analyses identify key genes and elucidate bidirectional regulatory mechanisms in thyroid dysfunction. | PLoS One | 2026 | 41570039 | PubTator, text mining | PubMed |
| Advanced molecular tools for surveillance and management of tobamoviruses. | Front Plant Sci | 2025 | 41613398 | PubTator, text mining | PubMed |
| Pan-Cancer Analysis of Cyclic Nucleotide Phosphodiesterases (PDEs) Expression, Variation, and Prognostic Significance. | ACS Omega | 2025 | 41476499 | PubTator, text mining | PubMed |
| Expanding disease resistance: engineered NLRS for broad-spectrum protection. | Mol Hortic | 2025 | 41276870 | PubTator, text mining | PubMed |
| Phosphodiesterase 7 inhibition reduces L-DOPA-induced dyskinesias in parkinsonian nonhuman primates. | J Pharmacol Exp Ther | 2025 | 41240765 | PubTator, text mining | PubMed |
| PDE7A inhibition suppresses triple-negative breast cancer by attenuating de novo pyrimidine biosynthesis. | Cell Rep Med | 2025 | 40961924 | PubTator, text mining | PubMed |
| Radiosynthesis and Preclinical Evaluation of a Carbon-11 Labeled Phosphodiesterase 7 Inhibitor for PET Neuroimaging. | ACS Med Chem Lett | 2025 | 40959257 | PubTator, text mining | PubMed |
| Mapping cancer heterogeneity: a consensus network approach to subtypes and pathways. | Brief Bioinform | 2025 | 40905375 | PubTator, text mining | PubMed |
| Inhibition of phosphodiesterase 4 and 7 regulates breast cancer cell proliferation. | Biochim Biophys Acta Gen Subj | 2025 | 40816541 | PubTator, text mining | PubMed |
| Does the Association Between Eye Disease and Cognitive Function Vary by Genetic Risk of Cognitive Decline? An Analysis of Hospital Data With Replication in the Canadian Longitudinal Study on Aging. | Invest Ophthalmol Vis Sci | 2025 | 40548629 | PubTator, text mining | PubMed |
| Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer. | Front Pharmacol | 2025 | 40535773 | PubTator, text mining | PubMed |
| Downregulation of CMIP contributes to preeclampsia development by impairing trophoblast function via the PDE7B-cAMP pathway. | Cell Mol Life Sci | 2025 | 40372501 | PubTator, text mining | PubMed |
| PDE7 as a Precision Target: Bridging Disease Modulation and Potential PET Imaging for Translational Medicine. | ACS Med Chem Lett | 2025 | 40365406 | PubTator, text mining | PubMed |
| Chemical Space Exploration and Machine Learning-Based Screening of PDE7A Inhibitors. | Pharmaceuticals (Basel) | 2025 | 40283882 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5150/papers